Vadim Koshkin: Genomic Biomarkers Associated with EV Outcomes for Patients with Advanced Urothelial Carcinoma
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a recent article by him and colleagues on X:
“Our latest Unite publication in European Urology Oncology led by Tanya Jindal.
Biomarkers of EV outcomes: TMB associated with improved OS while CDKN2A/CDKN2B alteration with inferior PFS.”
Authors: Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Rafee Talukder, Dimitra Bakaloudi, Matthew Davidsohn, Dory Freeman, Michael Glover, Ali Raza Khaki, Sean Evans, Emily Lemke, Rohit Bose, Woogwang Sim, Cameron Pywell, Arnab Basu, Deepak Kilari, Pedro C. Barata, Mehmet A. Bilen, Yousef Zakharia, Matthew I. Milowsky, Sumit A. Shah, Joaquim Bellmunt, Petros Grivas, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Christopher Holmes, Matthew T. Campbell, Ajjai Alva, Vadim S. Koshkin.
More posts featuring Vadim Koshkin.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023